Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003
Sleep apnoea and quality of life in growth hormone deficient adults before and six months following growth hormone therapy Source: Eur Respir J 2005; 26: Suppl. 49, 570s Year: 2005
New serum measures of the insulin like growth factor axis in children with asthma treated with exogenous glucocorticoids Source: Eur Respir J 2006; 28: Suppl. 50, 852s Year: 2006
Anabolic effects and safety assessments of TH9507, a growth hormone releasing factor (GRF) analog, in patients with COPD-associated wasting Source: Eur Respir J 2004; 24: Suppl. 48, 292s Year: 2004
Endocrinological derangements in COPD Source: Eur Respir J 2009; 34: 975-996 Year: 2009
Inhaled steroids in children: adrenal suppression and growth impairment Source: Eur Respir J 2002; 19: 985-988 Year: 2002
Analysis of sleep cyclic alternating pattern (CAP) in children with Prader-Willi syndrome and effect of growth hormone treatment Source: Annual Congress 2008 - Sleep apnoea in childhood Year: 2008
Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids Source: Eur Respir J 2001; 18: 115-121 Year: 2001
Growth hormone excess and sternohyoid muscle mechanics in rats Source: Eur Respir J 2009; 34: 967-974 Year: 2009
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Nerve growth factor levels and localisation in human asthmatic bronchi Source: Eur Respir J 2002; 20: 1110-1116 Year: 2002
Growth hormone-releasing hormone receptor antagonist MIA-602 modulates mouse lung inflammation and fibrosis due to bleomycin Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018
Growth hormone (GH) response to GH-releasing hormone (GHRH) in asthmatic patients during long-term inhaled corticosteroids (ICS) treatment Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
Growth hormone releasing hormone receptor (GHRH-R) antagonist MIA-602 modulates fibrosis and gene expression in lungs of bleomycin-treated mice Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019
Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Sleep apnoea and the hypothalamic–pituitary–adrenal axis in men and women: effects of continuous positive airway pressure Source: Eur Respir J 2016; 47: 531-540 Year: 2016
Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Source: Eur Respir J 2001; 17: 681-687 Year: 2001
Intrauterine growth restriction does not lead to impaired airway or lung growth in lambs: a morphometeric study Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps Source: Eur Respir J 2004; 24 : 594-600 Year: 2004